Beier Juliane I, Luyendyk James P, Guo Luping, von Montfort Claudia, Staunton Donald E, Arteel Gavin E
Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA.
Hepatology. 2009 May;49(5):1545-53. doi: 10.1002/hep.22847.
The early stages of alcohol-induced liver injury involve chronic inflammation. Whereas mechanisms by which this effect is mediated are not completely understood, it is hypothesized that enhanced sensitivity to circulating lipopolysaccharide (LPS) contributes to this process. It has recently been shown that ethanol induces activation of plasminogen activator inhibitor-1 (PAI-1). PAI-1 causes fibrin accumulation in liver by inhibiting degradation of fibrin (fibrinolysis). LPS also enhances fibrin accumulation by activating the coagulation cascade. It was therefore hypothesized that ethanol will synergistically increase fibrin accumulation caused by LPS, enhancing liver damage. Accordingly, the effect of ethanol pretreatment on LPS-induced liver injury and fibrin deposition was determined in mice. Ethanol enhanced liver damage caused by LPS, as determined by plasma parameters and histological indices of inflammation and damage. This effect was concomitant with a significant increase in PAI-1 expression. Extracellular fibrin accumulation caused by LPS was also robustly increased by ethanol preexposure. Coadministration of the thrombin inhibitor hirudin or the MEK (mitogen-activated protein kinase) inhibitor U0126 significantly attenuated the enhanced liver damage caused by ethanol preexposure; this protection correlated with a significant blunting of the induction of PAI-1 caused by ethanol/LPS. Furthermore, thrombin/MEK inhibition prevented the synergistic effect of ethanol on the extracellular accumulation of fibrin caused by LPS. Similar protective effects on fibrin accumulation were observed in tumor necrosis factor receptor 1 (TNFR-1)(-/-) mice or in wild-type injected with PAI-1-inactivating antibody.
These results suggest that enhanced LPS-induced liver injury caused by ethanol is mediated, at least in part, by fibrin accumulation in livers, mediated by an inhibition of fibrinolysis by PAI-1. These results also support the hypothesis that fibrin accumulation may play a critical role in the development of early alcohol-induced liver injury.
酒精性肝损伤的早期阶段涉及慢性炎症。虽然介导这种效应的机制尚未完全了解,但据推测,对循环脂多糖(LPS)的敏感性增强促成了这一过程。最近有研究表明,乙醇可诱导纤溶酶原激活物抑制剂-1(PAI-1)的活化。PAI-1通过抑制纤维蛋白降解(纤维蛋白溶解)导致肝脏中纤维蛋白积聚。LPS也通过激活凝血级联反应增强纤维蛋白积聚。因此,有人推测乙醇会协同增加LPS引起的纤维蛋白积聚,从而加重肝损伤。据此,在小鼠中确定了乙醇预处理对LPS诱导的肝损伤和纤维蛋白沉积的影响。乙醇增强了LPS引起的肝损伤,这通过血浆参数以及炎症和损伤的组织学指标得以确定。这种效应伴随着PAI-1表达的显著增加。乙醇预暴露也显著增加了LPS引起的细胞外纤维蛋白积聚。同时给予凝血酶抑制剂水蛭素或MEK(丝裂原活化蛋白激酶)抑制剂U0126可显著减轻乙醇预暴露引起的肝损伤加重;这种保护作用与乙醇/LPS引起的PAI-1诱导的显著减弱相关。此外,凝血酶/MEK抑制可防止乙醇对LPS引起的纤维蛋白细胞外积聚的协同作用。在肿瘤坏死因子受体1(TNFR-1)基因敲除小鼠或注射PAI-1失活抗体的野生型小鼠中观察到了对纤维蛋白积聚的类似保护作用。
这些结果表明,乙醇引起的LPS诱导的肝损伤增强至少部分是由肝脏中纤维蛋白积聚介导的,而纤维蛋白积聚是由PAI-1抑制纤维蛋白溶解介导的。这些结果也支持了纤维蛋白积聚可能在早期酒精性肝损伤发展中起关键作用的假说。